Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02089425 · ClinicalTrials.gov registry record · Phase 3

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

A Phase 3 study, sponsored by Kowa Research Institute.

Terminated
Registry status
Phase 3
Development phase
384
Enrollment target

NCT02089425: Clinical Trial Phase 3 study, sponsored by Kowa Research Institute.

NCT02089425 is a Phase 3 study that was terminated before completion, run by Kowa Research Institute. The registered enrollment target is 384 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02089425, a Phase 3 study, was terminated before completion, sponsored by Kowa Research Institute.

TERMINATED
Registry status
Phase 3
Development phase
384 participants
Enrollment target

Study Summary

This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.

Interventions

  • DRUG Placebo
  • DRUG K-103-IP

Trial Details

FieldValue
Enrollment Target 384 participants
Start Date 2014-04
Est. Completion 2014-12
Phase Phase 3
Kowa Research Institute

44 total trials

Why NCT02089425 stopped before completion

NCT02089425 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02089425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02089425 about?

NCT02089425 is a clinical study titled "An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.". This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.

What is the current status of trial NCT02089425?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 384 participants. The study started on 2014-04. Estimated completion is 2014-12.

What interventions are being tested in trial NCT02089425?

The interventions under investigation include: Placebo (DRUG), K-103-IP (DRUG).

Who is sponsoring clinical trial NCT02089425?

This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02089425's enrollment target sits among peer trials

384 975th of 2000 higher than 1,025 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

  • NCT06566703 · 384 participants · NA

    Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02089425, the US trial registry maintained by the National Library of Medicine. NCT02089425 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.